RefloDx is structured around development of better diagnostic devices allowing for earlier interventions, better experiences, and better lives. Current focus is on multi-Intraluminal Impedance (MII-pH) monitoring as a method of detecting Gastroesophageal Reflux (GER). Directly to tackle the highly invasive nature of MII-pH monitoring, RefloDx is addressing tackling development of new diagnostic devices and methods that are non-invasive while at the same time can provide clinicians with a procedure that captures quantitative data in assessing the frequency, duration, and volume of reflux occurring in their patients.
